Case of Chemotherapy-Refractory, <i>RAS</i>-Mutated Chronic Myelomonocytic Leukemia Responsive to Single-Agent Trametinib Based on Results From a High-Throughput Drug Screen.

Halpern, Anna B; Martins, Timothy J; Jonlin, Erica C; Dai, Jin; Chien, Sylvia; Becker, Pamela S

Case of Chemotherapy-Refractory, RAS-Mutated Chronic Myelomonocytic Leukemia Responsive to Single-Agent Trametinib Based on Results From a High-Throughput Drug Screen.

Halpern, Anna B; Martins, Timothy J; Jonlin, Erica C; Dai, Jin; Chien, Sylvia; Becker, Pamela S.

Afiliação

Halpern AB; Department of Medicine, Division of Hematology, University of Washington, Seattle, WA.
Martins TJ; Clinical Research Division, Fred Hutchinson Cancer Research Center/University of Washington, Seattle, WA.
Jonlin EC; Institute for Stem Cell and Regenerative Medicine, University of Washington, Seattle, WA.
Dai J; Institute for Stem Cell and Regenerative Medicine, University of Washington, Seattle, WA.
Chien S; Department of Medicine, Division of Hematology, University of Washington, Seattle, WA.
Becker PS; Department of Medicine, Division of Hematology, University of Washington, Seattle, WA.

JCO Precis Oncol ; 4: 1367-1373, 2020 Nov.

Article em En | MEDLINE | ID: mdl-35050791

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: JCO Precis Oncol Ano de publicação: 2020 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: JCO Precis Oncol Ano de publicação: 2020 Tipo de documento: Article